The U.S. Food and Drug Administration said Monday it is seeking public input on using approved drugs for new purposes across a range of diseases and conditions.
The agency said it wants feedback on possible new uses for FDA-approved drugs, including new disease indications or use in new patient groups, to help speed treatment availability by building on existing knowledge about those medicines.
The FDA said it is seeking information from patients, clinicians, researchers, and others on priority disease areas and possible drug candidates for repurposing, particularly where data supports new uses but incentives to seek approval are limited.
The agency said it is especially interested in input on metabolic diseases, neurodegenerative conditions, women’s and men’s health conditions, substance use disorders, and rare diseases.
It also asked for information on drug candidates with promising preliminary clinical data, including case reports and findings from artificial intelligence, that may warrant further study.